Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
e fold » 5 fold (Expand Search), _ fold (Expand Search), 2 fold (Expand Search)
5 mg » 5 mm (Expand Search)
Showing 81 - 100 results of 12,970 for search '(((( 5 mg decrease ) OR ( e fold decrease ))) OR ( 50 ((nn decrease) OR (we decrease)) ))', query time: 0.56s Refine Results
  1. 81
    Effect of remdesivir on invasive ventilation at 14 days.

    Effect of remdesivir on invasive ventilation at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  2. 82
    Effect of remdesivir on all-cause mortality at 14 days.

    Effect of remdesivir on all-cause mortality at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  3. 83
    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19.

    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  4. 84
    Description of characteristics of included studies.

    Description of characteristics of included studies. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  5. 85
    Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19.

    Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  6. 86
    Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19.

    Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  7. 87
    Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner.

    Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner. by Silvia Siteni (10344070)

    Published 2024
    Save to List
    Saved in:
  8. 88
    S1 Data -

    S1 Data - by Perumal Vivekanandhan (4863484)

    Published 2024
    “…Additionally, 12 hours post-treatment, catalase (an antioxidant enzyme) activity decreased 1.5-fold in a dose-dependent manner, while glutathione S-transferase (a detoxification enzyme) activity increased 7.8-fold. …”
    Save to List
    Saved in:
  9. 89
    Fig 5 -

    Fig 5 - by Saeed El-Ashram (710370)

    Published 2021
    Save to List
    Saved in:
  10. 90
    Fig 5 -

    Fig 5 - by Wenping Dong (3854437)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 91
    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from bladder cancer subjects.

    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 92
    Heatmap showing the end motifs of ucfDNA among different groups.

    Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 93
    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups.

    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 94
    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples with the availability of creatinine measurements (38 controls versus 21 bladder cancer patients).

    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples wi... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    Size distributions of ucfDNA molecules.

    Size distributions of ucfDNA molecules. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 96
    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice.

    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 97
    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay.

    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 98
    Overview of the study design.

    Overview of the study design. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 99
    The end density of ucfDNA across different tissue types.

    The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 100
    End density of the ucfDNA fragments within the DHSs.

    End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: